MedTech Spectrum

Article Name Clinical & Diagnostic

Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the launch and national availability of its ATN Profile, a blood-based test that combines three, well-researched blood biomarkers to identify and assess biological changes associated with Alzheimer's disease – amyloid plaques, tau tangles and neurodegeneration (ATN) – which can help accelerate the path to diagnosis and intervention.i The test is available through physicians for use with patients who are being evaluated for possible Alzheimer's disease or other causes of cognitive impairment based on clinical observation and cognitive screenings.

13th October, 2023

Brainomix and Nanoflex Robotics to Collaborate on an AI-Assisted Robotic System for Remote Stroke Intervention

Brainomix Awarded Innovate UK Grant to Collaborate with Swiss-based Nanoflex Robotics

13th October, 2023

Sigrid Therapeutics Announces First Patient Treated with SiPore21® Medical Device for Sustained Diabetes and Obesity Control

Sigrid Therapeutics announces the commencement of the SHINE clinical trial for SiPore21® – an innovative medical device designed for sustained diabetes and weight control. Based on Mesoporous Silica particles (MSPs), SiPore21® represents a groundbreaking approach to managing these pressing health concerns. Administered orally in gel form, MSPs act as "molecular sieves," physically preventing digestive enzymes from interacting with food, thereby reducing the breakdown of carbohydrates and fats.

11th October, 2023

DELFI Diagnostics Introduces FirstLook Lung: A Breakthrough in Blood-Based Lung Cancer Screening

FirstLook Lung uses a breakthrough technology of whole-genome machine learning to analyze fragments of cell-free DNA that are markers of cancer in the blood

11th October, 2023

BLK-Max Hospital collaborates with Intuitive to launch robot-assisted surgery fellowship training programme

Programme aims to address the growing demand for skilled robotic-assisted surgeons in India

11th October, 2023

Korean startup Noul enters cancer diagnostic biz with launch of cervical cell analysis product

To overcome the limitations of Human Papillomavirus (HPV) testing by identifying the detailed stages of cervical pre-cancer/cancer with cervical cytology

11th October, 2023

Make government’s guidelines universally enforceable to control hospital acquired infections: Experts

A nearly 30% increase in the mortality rate in hospitals can be attributed to poor infection management

09th October, 2023

“There is a need for more innovations in the way healthcare is delivered at the point-of-care level”

The reimagination of health systems in India is turning towards a central role being played by point-of-care tests that are accessible and affordable, to enable early detection and timely treatment of a number of diseases impacting India. This not only includes the current monsoon related spike in malaria cases that has surged by 40 per cent over last year's count, but also makes us reflect upon the fact that for the majority of tuberculosis (TB) testing, age-old microscopy technique still holds a major share. Addressing this demand for high-quality, point-of-care molecular diagnostic systems that is higher than ever today, Goa-based in-vitro diagnostic company Molbio Diagnostics is accelerating work on newer technologies. In conversation with MedTech Spectrum & BioSpectrum, Sriram Natarajan, Director and Chief Executive Officer, Molbio Diagnostics spoke in detail about the country’s healthcare challenges and the company’s contribution in attending to those challenges with novel ideas.

05th October, 2023

Transforming Healthcare With Generative AI

Generative AI is selling itself to emerge as the new frontier in the horizon for the booming healthcare industry. Highlighting some of the significant developments in this technology space, this article has a few Indian leaders voicing their opinions on exploring Generative AI to progress their businesses and services.

04th October, 2023

WHO recommends R21 vaccine for malaria prevention in updated advice on immunisation

R21 and RTS,S vaccines act against P. falciparum, the deadliest malaria parasite and the most prevalent on the African continent

04th October, 2023

Mylab transforms new-born screening with breakthrough point-of-care solution

Newborn screening is a critical public health program involving the testing of newborn infants for specific genetic, metabolic, and congenital disorders shortly after birth

29th September, 2023

Fujitsu and iSurgery Launch Osteoporosis Detection Project with Jikei University

Fujitsu Limited and iSurgery Co., Ltd. announced that they will conduct a field trial as part of their “bone health promotion project” from October 2023 to March 2025 in collaboration with the Department of Orthopaedic Surgery at the Jikei University School of Medicine (1), to verify the practicality of bone assessments (2) conducted with chest radiographs and the effects of this approach in changing Fujitsu employees’ attitudes and habits around health. This marks the first time in Japan that an employer is focusing on the improvement of this aspect of its employees’ health during their examinations through this novel use of chest radiographs for bone assessments.

26th September, 2023

NURA Health Screening Centre by Fujifilm opens in Mongolia

The first centre opened under a technology partnership contract

25th September, 2023

Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

Stryker’s PROstep MIS portfolio will be featured at the American Orthopaedic Foot & Ankle Society Annual Meeting

20th September, 2023

Remedi introduces affordable & innovative handheld X-ray solution in India

Unveils REMEX KA-6, a game-changing addition to the medical field

20th September, 2023

Mayo Clinic and GE HealthCare Enter Strategic Collaboration to Advance Innovation in Medical Imaging and Theranostics

Combining the world-class clinical and research expertise of Mayo Clinic with the deep research, engineering, and product development expertise of GE HealthCare, this new collaboration aims to forge an integrated innovation engine to advance the practice of radiology and care to patients worldwide.

18th September, 2023